Post Thumb

Researchers thwart cancer cells by triggering 'virus alert'

Working with human cancer cell lines and mice, researchers at the Johns Hopkins Kimmel Cancer Center and elsewhere have found a way to trigger a type of immune system “virus alert” that may one day boost cancer patients’ response to immunotherapy drugs. An increasingly promising focus of cancer research, the drugs are designed to disarm cancer cells’ ability to avoid detection and destruction by the immune system.

Post Thumb

Researchers thwart cancer cells by triggering ‘virus alert’

Working with human cancer cell lines and mice, researchers at the Johns Hopkins Kimmel Cancer Center and elsewhere have found a way to trigger a type of immune system “virus alert” that may one day boost cancer patients’ response to immunotherapy drugs. An increasingly promising focus of cancer research, the drugs are designed to disarm cancer cells’ ability to avoid detection and destruction by the immune system.

Post Thumb

Jimmy Carter and His ‘Breakthrough' Cancer Drug

Former president Jimmy Carter, who announced Thursday he has melanoma that had spread to his liver and brain, is being treated with two cutting-edge therapies that offer new hope to the 76,000 Americans diagnosed annually with this type of cancer. Carter, 90, explained in a news conference at the Carter Center in Atlanta that melanoma – most commonly occurring as skin cancer, but which can also cause internal tumors – had formed a mass in his liver, as well as …

Post Thumb

Jimmy Carter and His ‘Breakthrough’ Cancer Drug

Former president Jimmy Carter, who announced Thursday he has melanoma that had spread to his liver and brain, is being treated with two cutting-edge therapies that offer new hope to the 76,000 Americans diagnosed annually with this type of cancer. Carter, 90, explained in a news conference at the Carter Center in Atlanta that melanoma – most commonly occurring as skin cancer, but which can also cause internal tumors – had formed a mass in his liver, as well as …